Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1172 entries
Sorted by: Best Match Show Resources per page
Unconventional Molecular Design Approach of High-Efficiency Deep Blue Thermally Activated Delayed Fluorescent Emitters Using Indolocarbazole as an Acceptor.

ACS applied materials & interfaces

Seo JA, Im Y, Han SH, Lee CW, Lee JY.
PMID: 28980471
ACS Appl Mater Interfaces. 2017 Nov 01;9(43):37864-37872. doi: 10.1021/acsami.7b09351. Epub 2017 Oct 17.

Unconventional blue thermally activated delayed fluorescent emitters having electron-donating type indolocarbazole as an acceptor were developed by attaching carbazolylcarbazole or acridine donors to the indolocarbazole acceptor. Three compounds were derived from the indolocarbazole acceptor. The indolocarbazole-acridine combined products showed...

Cite
Seo JA, Im Y, Han SH, et al. Unconventional Molecular Design Approach of High-Efficiency Deep Blue Thermally Activated Delayed Fluorescent Emitters Using Indolocarbazole as an Acceptor. ACS Appl Mater Interfaces. 2017;9(43):37864-37872doi: 10.1021/acsami.7b09351.
Seo, J. A., Im, Y., Han, S. H., Lee, C. W., & Lee, J. Y. (2017). Unconventional Molecular Design Approach of High-Efficiency Deep Blue Thermally Activated Delayed Fluorescent Emitters Using Indolocarbazole as an Acceptor. ACS applied materials & interfaces, 9(43), 37864-37872. https://doi.org/10.1021/acsami.7b09351
Seo, Jeong-A, et al. "Unconventional Molecular Design Approach of High-Efficiency Deep Blue Thermally Activated Delayed Fluorescent Emitters Using Indolocarbazole as an Acceptor." ACS applied materials & interfaces vol. 9,43 (2017): 37864-37872. doi: https://doi.org/10.1021/acsami.7b09351
Seo JA, Im Y, Han SH, Lee CW, Lee JY. Unconventional Molecular Design Approach of High-Efficiency Deep Blue Thermally Activated Delayed Fluorescent Emitters Using Indolocarbazole as an Acceptor. ACS Appl Mater Interfaces. 2017 Nov 01;9(43):37864-37872. doi: 10.1021/acsami.7b09351. Epub 2017 Oct 17. PMID: 28980471.
Copy Download .nbib Format: NLM
Weakness of the Pelvic Floor Muscle and Bladder Neck Is Predicted by a Slight Rise in Abdominal Pressure During Bladder Filling: A Video Urodynamic Study in Children.

International neurourology journal

Shin SH, Im YJ, Lee YS, Kim JH, Han SW.
PMID: 27032558
Int Neurourol J. 2016 Mar;20(1):53-8. doi: 10.5213/inj.1630392.196. Epub 2016 Mar 30.

PURPOSE: To investigate the significance of slowly rising abdominal pressure (SRAP), which is often observed in nonneurogenic children during bladder filling in video urodynamic studies (VUDSs).METHODS: The records of patients who underwent VUDS from July 2011 to June 2013...

Cite
Shin SH, Im YJ, Lee YS, et al. Weakness of the Pelvic Floor Muscle and Bladder Neck Is Predicted by a Slight Rise in Abdominal Pressure During Bladder Filling: A Video Urodynamic Study in Children. Int Neurourol J. 2016;20(1):53-8doi: 10.5213/inj.1630392.196.
Shin, S. H., Im, Y. J., Lee, Y. S., Kim, J. H., & Han, S. W. (2016). Weakness of the Pelvic Floor Muscle and Bladder Neck Is Predicted by a Slight Rise in Abdominal Pressure During Bladder Filling: A Video Urodynamic Study in Children. International neurourology journal, 20(1), 53-8. https://doi.org/10.5213/inj.1630392.196
Shin, Sang Hee, et al. "Weakness of the Pelvic Floor Muscle and Bladder Neck Is Predicted by a Slight Rise in Abdominal Pressure During Bladder Filling: A Video Urodynamic Study in Children." International neurourology journal vol. 20,1 (2016): 53-8. doi: https://doi.org/10.5213/inj.1630392.196
Shin SH, Im YJ, Lee YS, Kim JH, Han SW. Weakness of the Pelvic Floor Muscle and Bladder Neck Is Predicted by a Slight Rise in Abdominal Pressure During Bladder Filling: A Video Urodynamic Study in Children. Int Neurourol J. 2016 Mar;20(1):53-8. doi: 10.5213/inj.1630392.196. Epub 2016 Mar 30. PMID: 27032558; PMCID: PMC4819155.
Copy Download .nbib Format: NLM
Promoter polymorphisms of the vascular endothelial growth factor gene are associated with metabolic syndrome susceptibility in Koreans.

Biomedical reports

Kim YR, Hong SH.
PMID: 28515913
Biomed Rep. 2017 May;6(5):555-560. doi: 10.3892/br.2017.886. Epub 2017 Apr 07.

Vascular endothelial growth factor (VEGF) is a potent regulator of angiogenesis. Patients with metabolic syndrome (MetS) have elevated plasma VEGF levels. The aim of the present study was to investigate the association between promoter polymorphisms (the -2578C>A and -1154G>A)...

Cite
Kim YR, Hong SH. Promoter polymorphisms of the vascular endothelial growth factor gene are associated with metabolic syndrome susceptibility in Koreans. Biomed Rep. 2017;6(5):555-560doi: 10.3892/br.2017.886.
Kim, Y. R., & Hong, S. H. (2017). Promoter polymorphisms of the vascular endothelial growth factor gene are associated with metabolic syndrome susceptibility in Koreans. Biomedical reports, 6(5), 555-560. https://doi.org/10.3892/br.2017.886
Kim, Young Ree, and Hong, Seung-Ho. "Promoter polymorphisms of the vascular endothelial growth factor gene are associated with metabolic syndrome susceptibility in Koreans." Biomedical reports vol. 6,5 (2017): 555-560. doi: https://doi.org/10.3892/br.2017.886
Kim YR, Hong SH. Promoter polymorphisms of the vascular endothelial growth factor gene are associated with metabolic syndrome susceptibility in Koreans. Biomed Rep. 2017 May;6(5):555-560. doi: 10.3892/br.2017.886. Epub 2017 Apr 07. PMID: 28515913; PMCID: PMC5431263.
Copy Download .nbib Format: NLM
Optimization and multigram scalability of a catalytic enantioselective borylative migration for the synthesis of functionalized chiral piperidines.

Organic & biomolecular chemistry

Kim YR, Hall DG.
PMID: 27143333
Org Biomol Chem. 2016 May 18;14(20):4739-48. doi: 10.1039/c6ob00685j.

The development of new, efficient and economical methods for the preparation of functionalized, optically enriched piperidines is important in the field of drug discovery where this class of heterocycles is often deemed a privileged structure. We have optimized a...

Cite
Kim YR, Hall DG. Optimization and multigram scalability of a catalytic enantioselective borylative migration for the synthesis of functionalized chiral piperidines. Org Biomol Chem. 2016;14(20):4739-48doi: 10.1039/c6ob00685j.
Kim, Y. R., & Hall, D. G. (2016). Optimization and multigram scalability of a catalytic enantioselective borylative migration for the synthesis of functionalized chiral piperidines. Organic & biomolecular chemistry, 14(20), 4739-48. https://doi.org/10.1039/c6ob00685j
Kim, You-Ri, and Hall, Dennis G. "Optimization and multigram scalability of a catalytic enantioselective borylative migration for the synthesis of functionalized chiral piperidines." Organic & biomolecular chemistry vol. 14,20 (2016): 4739-48. doi: https://doi.org/10.1039/c6ob00685j
Kim YR, Hall DG. Optimization and multigram scalability of a catalytic enantioselective borylative migration for the synthesis of functionalized chiral piperidines. Org Biomol Chem. 2016 May 18;14(20):4739-48. doi: 10.1039/c6ob00685j. PMID: 27143333.
Copy Download .nbib Format: NLM
Characterization of a Biflaviolin Synthase CYP158A3 from .

Biomolecules & therapeutics

Lim YR, Han S, Kim JH, Park HG, Lee GY, Le TK, Yun CH, Kim D.
PMID: 27956713
Biomol Ther (Seoul). 2017 Mar 01;25(2):171-176. doi: 10.4062/biomolther.2016.182.

No abstract available.

Cite
Lim YR, Han S, Kim JH, et al. Characterization of a Biflaviolin Synthase CYP158A3 from . Biomol Ther (Seoul). 2017;25(2):171-176doi: 10.4062/biomolther.2016.182.
Lim, Y. R., Han, S., Kim, J. H., Park, H. G., Lee, G. Y., Le, T. K., Yun, C. H., & Kim, D. (2017). Characterization of a Biflaviolin Synthase CYP158A3 from . Biomolecules & therapeutics, 25(2), 171-176. https://doi.org/10.4062/biomolther.2016.182
Lim, Young-Ran, et al. "Characterization of a Biflaviolin Synthase CYP158A3 from ." Biomolecules & therapeutics vol. 25,2 (2017): 171-176. doi: https://doi.org/10.4062/biomolther.2016.182
Lim YR, Han S, Kim JH, Park HG, Lee GY, Le TK, Yun CH, Kim D. Characterization of a Biflaviolin Synthase CYP158A3 from . Biomol Ther (Seoul). 2017 Mar 01;25(2):171-176. doi: 10.4062/biomolther.2016.182. PMID: 27956713; PMCID: PMC5340542.
Copy Download .nbib Format: NLM
Surface Modification of Li(Ni.

Materials (Basel, Switzerland)

Yoo KS, Kang YH, Im KR, Kim CS.
PMID: 29113128
Materials (Basel). 2017 Nov 06;10(11). doi: 10.3390/ma10111273.

Al₂O₃-coated Li(Ni

Cite
Yoo KS, Kang YH, Im KR, et al. Surface Modification of Li(Ni. Materials (Basel). 2017;10(11)doi: 10.3390/ma10111273.
Yoo, K. S., Kang, Y. H., Im, K. R., & Kim, C. S. (2017). Surface Modification of Li(Ni. Materials (Basel, Switzerland), 10(11), . https://doi.org/10.3390/ma10111273
Yoo, Kwang Soo, et al. "Surface Modification of Li(Ni." Materials (Basel, Switzerland) vol. 10,11 (2017). doi: https://doi.org/10.3390/ma10111273
Yoo KS, Kang YH, Im KR, Kim CS. Surface Modification of Li(Ni. Materials (Basel). 2017 Nov 06;10(11). doi: 10.3390/ma10111273. PMID: 29113128; PMCID: PMC5706220.
Copy Download .nbib Format: NLM
Promotion of Tumor Invasion by Tumor-Associated Macrophages: The Role of CSF-1-Activated Phosphatidylinositol 3 Kinase and Src Family Kinase Motility Signaling.

Cancers

Dwyer AR, Greenland EL, Pixley FJ.
PMID: 28629162
Cancers (Basel). 2017 Jun 18;9(6). doi: 10.3390/cancers9060068.

Macrophages interact with cells in every organ to facilitate tissue development, function and repair. However, the close interaction between macrophages and parenchymal cells can be subverted in disease, particularly cancer. Motility is an essential capacity for macrophages to be...

Cite
Dwyer AR, Greenland EL, Pixley FJ. Promotion of Tumor Invasion by Tumor-Associated Macrophages: The Role of CSF-1-Activated Phosphatidylinositol 3 Kinase and Src Family Kinase Motility Signaling. Cancers (Basel). 2017;9(6)doi: 10.3390/cancers9060068.
Dwyer, A. R., Greenland, E. L., & Pixley, F. J. (2017). Promotion of Tumor Invasion by Tumor-Associated Macrophages: The Role of CSF-1-Activated Phosphatidylinositol 3 Kinase and Src Family Kinase Motility Signaling. Cancers, 9(6), . https://doi.org/10.3390/cancers9060068
Dwyer, Amy R, et al. "Promotion of Tumor Invasion by Tumor-Associated Macrophages: The Role of CSF-1-Activated Phosphatidylinositol 3 Kinase and Src Family Kinase Motility Signaling." Cancers vol. 9,6 (2017). doi: https://doi.org/10.3390/cancers9060068
Dwyer AR, Greenland EL, Pixley FJ. Promotion of Tumor Invasion by Tumor-Associated Macrophages: The Role of CSF-1-Activated Phosphatidylinositol 3 Kinase and Src Family Kinase Motility Signaling. Cancers (Basel). 2017 Jun 18;9(6). doi: 10.3390/cancers9060068. PMID: 28629162; PMCID: PMC5483887.
Copy Download .nbib Format: NLM
SIRT1 Inhibits p53 but not NF-κB Transcriptional Activity during Differentiation of Mouse Embryonic Stem Cells into Embryoid Bodies.

International journal of stem cells

Lhee SJ, Song EK, Kim YR, Han MK.
PMID: 24298365
Int J Stem Cells. 2012 Nov;5(2):125-9. doi: 10.15283/ijsc.2012.5.2.125.

BACKGROUND AND OBJECTIVES: SIRT1, a histone diacetylase, modify transactivation function of various transcription factor including p53 and NF-κB. p53 and NF-κB is involved in in vitro differentiation of mouse embryonic stem cells (mESC) into mouse embryoid body (mEB). These...

Cite
Lhee SJ, Song EK, Kim YR, et al. SIRT1 Inhibits p53 but not NF-κB Transcriptional Activity during Differentiation of Mouse Embryonic Stem Cells into Embryoid Bodies. Int J Stem Cells. 2012;5(2):125-9doi: 10.15283/ijsc.2012.5.2.125.
Lhee, S. J., Song, E. K., Kim, Y. R., & Han, M. K. (2012). SIRT1 Inhibits p53 but not NF-κB Transcriptional Activity during Differentiation of Mouse Embryonic Stem Cells into Embryoid Bodies. International journal of stem cells, 5(2), 125-9. https://doi.org/10.15283/ijsc.2012.5.2.125
Lhee, Sang Jae, et al. "SIRT1 Inhibits p53 but not NF-κB Transcriptional Activity during Differentiation of Mouse Embryonic Stem Cells into Embryoid Bodies." International journal of stem cells vol. 5,2 (2012): 125-9. doi: https://doi.org/10.15283/ijsc.2012.5.2.125
Lhee SJ, Song EK, Kim YR, Han MK. SIRT1 Inhibits p53 but not NF-κB Transcriptional Activity during Differentiation of Mouse Embryonic Stem Cells into Embryoid Bodies. Int J Stem Cells. 2012 Nov;5(2):125-9. doi: 10.15283/ijsc.2012.5.2.125. PMID: 24298365; PMCID: PMC3840997.
Copy Download .nbib Format: NLM
Metal-free azaphosphaannulation of phosphonamides through intramolecular oxidative C-N bond formation.

Organic letters

Kim YR, Cho S, Lee PH.
PMID: 24867436
Org Lett. 2014 Jun 06;16(11):3098-101. doi: 10.1021/ol501207w. Epub 2014 May 27.

We report an efficient metal-free azaphosphaannulation of a myriad of phosphonamides through intramolecular oxidative C-N bond formation using PhI(OAc)2 and iodine in acetonitrile under air, thus leading to the formation of benzazaphosphol-3-one 1-oxides, which are novel phosphorus heterocyclic privileged...

Cite
Kim YR, Cho S, Lee PH. Metal-free azaphosphaannulation of phosphonamides through intramolecular oxidative C-N bond formation. Org Lett. 2014;16(11):3098-101doi: 10.1021/ol501207w.
Kim, Y. R., Cho, S., & Lee, P. H. (2014). Metal-free azaphosphaannulation of phosphonamides through intramolecular oxidative C-N bond formation. Organic letters, 16(11), 3098-101. https://doi.org/10.1021/ol501207w
Kim, Yea Rin, et al. "Metal-free azaphosphaannulation of phosphonamides through intramolecular oxidative C-N bond formation." Organic letters vol. 16,11 (2014): 3098-101. doi: https://doi.org/10.1021/ol501207w
Kim YR, Cho S, Lee PH. Metal-free azaphosphaannulation of phosphonamides through intramolecular oxidative C-N bond formation. Org Lett. 2014 Jun 06;16(11):3098-101. doi: 10.1021/ol501207w. Epub 2014 May 27. PMID: 24867436.
Copy Download .nbib Format: NLM
Reaction Event Counting Statistics of Biopolymer Reaction Systems with Dynamic Heterogeneity.

Journal of chemical theory and computation

Lim YR, Park SJ, Park BJ, Cao J, Silbey RJ, Sung J.
PMID: 26596754
J Chem Theory Comput. 2012 Apr 10;8(4):1415-25. doi: 10.1021/ct200785q. Epub 2012 Mar 16.

We investigate the reaction event counting statistics (RECS) of an elementary biopolymer reaction in which the rate coefficient is dependent on states of the biopolymer and the surrounding environment and discover a universal kinetic phase transition in the RECS...

Cite
Lim YR, Park SJ, Park BJ, et al. Reaction Event Counting Statistics of Biopolymer Reaction Systems with Dynamic Heterogeneity. J Chem Theory Comput. 2012;8(4):1415-25doi: 10.1021/ct200785q.
Lim, Y. R., Park, S. J., Park, B. J., Cao, J., Silbey, R. J., & Sung, J. (2012). Reaction Event Counting Statistics of Biopolymer Reaction Systems with Dynamic Heterogeneity. Journal of chemical theory and computation, 8(4), 1415-25. https://doi.org/10.1021/ct200785q
Lim, Yu Rim, et al. "Reaction Event Counting Statistics of Biopolymer Reaction Systems with Dynamic Heterogeneity." Journal of chemical theory and computation vol. 8,4 (2012): 1415-25. doi: https://doi.org/10.1021/ct200785q
Lim YR, Park SJ, Park BJ, Cao J, Silbey RJ, Sung J. Reaction Event Counting Statistics of Biopolymer Reaction Systems with Dynamic Heterogeneity. J Chem Theory Comput. 2012 Apr 10;8(4):1415-25. doi: 10.1021/ct200785q. Epub 2012 Mar 16. PMID: 26596754.
Copy Download .nbib Format: NLM
A Multi-Center, Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Cisplatin for Patients with Non-Small Cell Lung Cancer.

Cancer research and treatment

Lee SH, Park K, Suh C, Kim HK, Kim JS, Im YH, Kim SW, Heo DS, Bang YJ, Kim NK.
PMID: 26680912
Cancer Res Treat. 2003 Feb;35(1):30-4. doi: 10.4143/crt.2003.35.1.30.

PURPOSE: A combination of paclitaxel and cisplatin is an effective and safe regimen for advanced non-small cell lung cancer (NSCLC). We conducted a multi-center, phase II trial to evaluate the efficacy and safety of Genexol(R) (paclitaxel) and cisplatin in...

Cite
Lee SH, Park K, Suh C, et al. A Multi-Center, Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Cisplatin for Patients with Non-Small Cell Lung Cancer. Cancer Res Treat. 2003;35(1):30-4doi: 10.4143/crt.2003.35.1.30.
Lee, S. H., Park, K., Suh, C., Kim, H. K., Kim, J. S., Im, Y. H., Kim, S. W., Heo, D. S., Bang, Y. J., & Kim, N. K. (2003). A Multi-Center, Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Cisplatin for Patients with Non-Small Cell Lung Cancer. Cancer research and treatment, 35(1), 30-4. https://doi.org/10.4143/crt.2003.35.1.30
Lee, Se Hoon, et al. "A Multi-Center, Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Cisplatin for Patients with Non-Small Cell Lung Cancer." Cancer research and treatment vol. 35,1 (2003): 30-4. doi: https://doi.org/10.4143/crt.2003.35.1.30
Lee SH, Park K, Suh C, Kim HK, Kim JS, Im YH, Kim SW, Heo DS, Bang YJ, Kim NK. A Multi-Center, Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Cisplatin for Patients with Non-Small Cell Lung Cancer. Cancer Res Treat. 2003 Feb;35(1):30-4. doi: 10.4143/crt.2003.35.1.30. PMID: 26680912.
Copy Download .nbib Format: NLM
Use of GCDFP-15 (BRST-2) as a Specific Immunocytochemical Marker for Diagnosis of Gastric Metastasis of Breast Carcinoma.

Cancer research and treatment

Park KW, Im YH, Lee J, Kim E, Lee H, Song BG, Park JO, Kim K, Jung CW, Park YS, Kang WK, Lee MH, Park K.
PMID: 26680974
Cancer Res Treat. 2003 Oct;35(5):460-4. doi: 10.4143/crt.2003.35.5.460.

Metastasis of breast cancer to the stomach is relatively uncommon and typically occurs in patients with disseminated diseases. This may cause difficulty in differentiating it from primary gastric carcinoma. The correct diagnosis of the primary source is important, since...

Cite
Park KW, Im YH, Lee J, et al. Use of GCDFP-15 (BRST-2) as a Specific Immunocytochemical Marker for Diagnosis of Gastric Metastasis of Breast Carcinoma. Cancer Res Treat. 2003;35(5):460-4doi: 10.4143/crt.2003.35.5.460.
Park, K. W., Im, Y. H., Lee, J., Kim, E., Lee, H., Song, B. G., Park, J. O., Kim, K., Jung, C. W., Park, Y. S., Kang, W. K., Lee, M. H., & Park, K. (2003). Use of GCDFP-15 (BRST-2) as a Specific Immunocytochemical Marker for Diagnosis of Gastric Metastasis of Breast Carcinoma. Cancer research and treatment, 35(5), 460-4. https://doi.org/10.4143/crt.2003.35.5.460
Park, Keon Woo, et al. "Use of GCDFP-15 (BRST-2) as a Specific Immunocytochemical Marker for Diagnosis of Gastric Metastasis of Breast Carcinoma." Cancer research and treatment vol. 35,5 (2003): 460-4. doi: https://doi.org/10.4143/crt.2003.35.5.460
Park KW, Im YH, Lee J, Kim E, Lee H, Song BG, Park JO, Kim K, Jung CW, Park YS, Kang WK, Lee MH, Park K. Use of GCDFP-15 (BRST-2) as a Specific Immunocytochemical Marker for Diagnosis of Gastric Metastasis of Breast Carcinoma. Cancer Res Treat. 2003 Oct;35(5):460-4. doi: 10.4143/crt.2003.35.5.460. PMID: 26680974.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1172 entries